| |
CONTENTS OF THIS SECTION
-
Summary
-
JRC's
Basic Policy Regarding Psychotropic Medication
-
Primer on Psychotropic Drugs
-
Advantages of Aversive
Therapy in the Form of the Graduated Electronic Decelerator (GED) Over
Psychotropic Drugs and Restraint
-
Common Side Effects of Psychotropic
Medications
-
Side Effects of Common
Medications
-
PBS Frontline program, "The Medicated Child"
-
Articles on the negative side effects of psychotropic medication
-
Mad in America
-
Brain
Disabling Treatments in Psychiatry
-
The History Behind
the Use of Antipsychotic Medications in Persons with Intellectual
Disability", Part 1
-
"The History
Behind the Use of Antipsychotic Medications in Persons with Intellectual
Disability", Part 2
-
"Antipsychotics
for Aggression Unrelated to A Psychiatric Diagnosis"
-
"Drugs Offer No
Benefit in Curbing Aggression, Study Finds", 1/4/08
-
Link to Depression
in Kids on Risperidone, 7/18/07
-
"Psychiatrists, Children and Drug Industry's Role", 5/10/07
-
"FDA Proposes New
Warnings About Suicidal Thinking, Behavior in Young Adults Who Take
Antidepressant Medications",
5/2/07
-
"Are Meds to Blame for
Cho's Rampage?", 4/23/07
-
"Child's Overdose
Death Raises Questions", 3/23/07
-
"Choosing the Right
Antipsychotic", 3/07
-
"International Warnings on Psychiatric Drugs Since 2004"
-
"Activists Take on
Eli Lilly Over Sale of Zyprexa", 2/27/07
-
"ADHD Drug Makers to
Warn of Side Effects", 2/22/07
-
"Debate Over
Children and Psychiatric Drugs", 2/15/07
-
"FDA handling of Lilly drug needs probe: scientist", 2/13/07
-
"Girl fed fatal overdoses, court told", 2/7/07
-
"Parenting as
Therapy for Child's Mental Disorders", 12/22/06
-
"Proof is Scant on
Psychiatric Drug Mix for Young", 11/23/06
-
"ADHD drugs to carry new
warnings about psychotic behavior", 8/22/06
-
"Use of
Antipsychotics by the Young Rose Fivefold", 6/6/06
-
"Anti-psychotic drug use in kids skyrockets", 3/16/06
-
"Pharmacoepidemiology and Pediatric Psychopharmacology Research",
2005
-
"Worsening
Depression and Suicidality in Patients Being Treated with Antidepressants",
3/22/04
-
"Review of Safety
Assessment Methods Used in Pediatric Psychopharmacology", 6/03
-
"Parents Crusade
Over Children's Tragic Deaths from Psychiatric Drugs", 11/4/02
-
"Against
Depression, a Sugar Pill is Hard to Beat", 5/7/02
-
"Psychopharmacology for Young Children: Clinical Needs and Research
Opportunities", 10/01
-
"Critical Review of
Tricyclic Antidepressant Use in Children and Adolescents", 5/99
-
"Challenges to
Pediatric Psychopharmacology", 1997
-
"Pharmacotherapy in mental retardation and autism"
-
"CA Medications
Error Panel Report"
-
"An Assault on the Human
Condition"
-
"Regarding
Allegations Made by the New York State Commission on the Quality of Care
for the Mentally Disabled"
-
"What Eli Lilly (Prozac)
and Novartis (Ritalin) Would Rather You Didn't Know"
JRC's Policy
on
Psychotropic Medication
Summary
We
try to eliminate or minimize the use of psychotropic medication; however,
we do employ it, as an additional component of the student’s total
treatment program, when objective behavior data shows that it is needed to
maximize treatment effectiveness.
JRC is designed and staffed to provide a highly
structured, intensive behavioral treatment program for severe behavior
disorders. JRC has found that properly designed behavioral treatment is
the most effective treatment available for behavior disorders in most
cases. The treatment carries no risk of serious side effects. JRC's
behavioral treatment is often a more effective and safer alternative to
treating behavior disorders with psychotropic medications. The use of
psychotropic medication has many problems, including these: the serious
and disabling physical side effects, such as permanent damage to the
nervous system; impairment of cognitive functioning which can diminish
learning ability; lack of reliable evidence of psychotropic medications’
effectiveness in treating behavior disorders; and psychotropic medication’s
inability to be targeted at specific behaviors. Although JRC is capable of
implementing psychotropic drug treatment programs, and does so for a small
number of clients under certain conditions, parents seeking such treatment
for their child should consider other placements that specialize in that
form of treatment.
JRC’s Basic Policy Regarding
Psychotropic Medication
JRC specializes in providing a highly structured
behavior modification treatment program combined with behavioral
counseling and a behavioral education program. This approach has proven to
be extremely effective in treating a wide range of behavioral problems. In
providing this treatment, it is JRC’s policy to avoid, or at least
minimize the use of psychotropic medication. Although JRC has the ability
to administer psychotropic drugs as part of its treatment, has done so in
the past and continues to do so at present with a few of its students, the
major thrust of JRC’s treatment approach is to accomplish the needed
changes in its students without resort to psychotropic medication. This
enables JRC to avoid the undesirable and sometimes permanently disabling
effects of psychotropic medication.
Treatment with psychotropic drugs is available in
many other programs that provide such medication as an integral part of
their treatment. Parents who strongly believe that their child requires
the use of psychotropic medication and who are not interested in trying an
approach, which avoids or minimizes such medication, are encouraged to
consider enrolling their child in such programs rather than in JRC.
Students who are receiving psychotropic medication
when they are enrolled in JRC will be seen by a psychiatrist after their
enrollment for purposes of planning a program of medication reduction.
Parents of JRC students, as well as the students themselves, are usually
very pleased with the results that we area able to achieve with a
non-drug, behavioral approach.
JRC admits students whose parents are seeking
effective behavioral treatment. Sometimes these are students who have
received no benefit from prior drug treatments and may have suffered
adverse side effects from such drugs. We consider the use of psychotropic
medication only after we are satisfied that behavioral procedures alone
have proven to be insufficiently effective. We reach this point only after
behavioral procedures alone have been given a thorough trial.
Currently there are some students at JRC who have
reached this point and are receiving psychotropic medication as part of
their treatment program under the direction of a psychiatrist. We may also
use psychotropic medications when they are recommended by one of our
consulting psychiatrists as a needed emergency measure. Prospective
parents should understand, however, that these cases in which psychotropic
medication is used at JRC tend to be the exceptions rather than the rule.
Our policy concerning psychotropic medication policy
does not apply to cases of students who suffer from medical problems which
require drug treatment or neuroleptic seizures.
Problems with the Use of
Psychotropic Medication
JRC’s reasons for avoiding and minimizing the use
of psychotropic medication whenever possible are these:
- Psychotropic medications have often proved to
have negative, and sometimes even poisonous, side effects that may not
be recognized until years after the drug was first introduced to
general use. Some psychotropic medications have proven to have
extremely detrimental effects on the nervous system that are
irreversible. By contrast, the behavioral procedures employed by JRC
appear to have no significant side effects.
- There is some evidence that psychotropic
medication may interfere with a behavioral program by making
behavioral procedures less effective than they otherwise might be.
- The available evidence for the effectiveness of
psychotropic medication is often based largely on case studies in
which careful experimental controls have not been used. It
requires a relatively difficult and time consuming experimental
process to make sure that psychotropic medication is effective. To be
certain that a drug is effective in treating a behavioral problem the
following should be done:
- The psychiatric problem should be defined in
terms of the frequency of certain problematic behaviors. Objective
data should be collected continuously on these behaviors before
during and after the use of the medication;
- One should learn enough about the normal
variability of these behaviors, during a period when the medication
in question is not given, in order to be sure that any apparent
improvement that the drug produces is not due to this normal
variability;
- When the drug is introduced, the dosage should
be adequate and must be ingested by, or otherwise introduced into,
the individual;
- Ideally, the individual’s caretakers, and
those who are conducting the study, should be unaware of the date
when the drug is introduced or removed. (The study should be
"blind.")
- During the period of time when the medication is
being tried as a treatment, other educational and treatment
procedures should be held constant;
- If improvement is seen when the drug is
introduced, the drug should then be removed at a later point to see
if the improvement will stay in place without the medication; and
- The individual should be followed
up periodically by a trained
clinician.
Because such procedures are not followed in many of the reported studies
on the effects of
psychotropic medication, such studies are not entirely reliable as a basis for
making treatment decisions. By contrast, the effectiveness of behavioral
treatment procedures tends to be very carefully researched in controlled
scientific studies.
- Carefully
controlled evaluations of drugs are rarely if ever used to determine if
a psychotropic
medication, once it has been prescribed, needs to be continued.
As a result, students in
other programs are sometimes placed on psychotropic medications and
allowed to remain on them for long periods of time without clear
evidence either
that they were necessary in the first place or that they continue to be necessary. By
contrast, the effects of behavioral interventions can generally be seen quickly and
objectively within an environment such as JRC that measures behavior
on a daily basis.
- Psychotropic
medications are not able to be focused on a single behavior. Sometimes such
medications affect the entire repertoire of the individual.
By contrast,
behavioral procedures can be precisely focused on a single
behavior.
What this Means for Parents
Applying for Admission to JRC
- Because of these problems with the use of
psychotropic medication, parents should understand that JRC employs
its non-drug, behavioral treatment, education and counseling program
to treat psychological problems that in other programs might be
treated with psychotropic medication. Examples are psychosis,
depression, anxiety, conduct disorder, suicidal tendencies and other
psychiatric symptoms when our consulting psychiatrist has determined
that our behavioral treatment is the least restrictive and most
effective treatment for the student.
- If a parent seeking admission to JRC wishes
his/her child to continue with the use of any psychotropic medication
or if the parent wants his/her child to be treated with a combination
of behavior modification and psychotropic medication, our staff would
have to consult most carefully with such a parent before accepting the
child into the JRC program because the child may be more suitable for
another program . . .
- If, after a child enters JRC, his/her parents
change their mind and decide that they want psychotropic medication
used with their child, JRC may be unable to provide those services
other than on a short-term transitional basis. This short-term use
assumes that JRC’s medical and clinical services staff concurs that drug
treatment can be safely implemented. In such cases, JRC will also
initiate an IEP meeting and ask the placement agency to find an
alternative placement where the child will be able to receive the
treatment that the parent now wishes.
- Students receiving psychotropic medication at the
time of admission to JRC, will be removed from such medication after
they are enrolled in JRC, in accordance with a schedule determined by
our psychiatrist and agreed to by the parents.
Situations in Which Psychotropic
Medication Might be Used at JRC
The only cases in which psychotropic medication is
used at JRC are those that fit one or more of the descriptions listed
below. Currently (as of January 2000) only 7 out of 115 of our students
are receiving any psychotropic medication:
- We have exhausted our behavior modification
treatment procedures and believe we can make little further progress
on one or more behavior problems without trying the addition of
psychotropic medication. In these cases we may add psychotropic
medication as a supplement to the ongoing behavioral treatment. If the
student improves when this is done, we will also take steps to
evaluate whether the medication has been a critical component of that
improvement. This will be done, with the permission of the parents and
under the supervision of a psychiatrist, by removing the medication
for a certain period of time and determining whether improvement
continues even after the medication has been removed.
- The student has displayed an extremely
dangerous, life-threatening behavior (e.g. serious suicidal
action) and a psychiatrist has recommended that his/her treatment
should include some psychotropic medication. Again, if the student
does well while under the medication, we will, at some later date,
evaluate whether the medication needs to be continued. If it is not,
the medication will be discontinued.
- The student is awaiting a transfer to some
other program, the parents desire psychotropic medication to be
used until the transfer is effected, the JRC medical and psychological
staff concur that drug treatment can be safely implemented and JRC has
the necessary legal authority to administer the medication.
- A judge has ordered that psychotropic
medication be maintained.
v9

Return to Key Features |